These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10999937)

  • 1. A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11beta-substituted spirolactones.
    Auzou G; Fagart J; Souque A; Hellal-Lévy C; Wurtz JM; Moras D; Rafestin-Oblin ME
    Mol Pharmacol; 2000 Oct; 58(4):684-91. PubMed ID: 10999937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimineralocorticoid 11beta-substituted spirolactones exhibit androgen receptor agonistic activity: a structure function study.
    Nirdé P; Térouanne B; Gallais N; Sultan C; Auzou G
    Mol Pharmacol; 2001 May; 59(5):1307-13. PubMed ID: 11306716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor.
    Hellal-Levy C; Fagart J; Souque A; Wurtz JM; Moras D; Rafestin-Oblin ME
    Mol Endocrinol; 2000 Aug; 14(8):1210-21. PubMed ID: 10935545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism in the human mineralocorticoid receptor.
    Fagart J; Wurtz JM; Souque A; Hellal-Levy C; Moras D; Rafestin-Oblin ME
    EMBO J; 1998 Jun; 17(12):3317-25. PubMed ID: 9628869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11beta-hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells.
    Rafestin-Oblin ME; Fagart J; Souque A; Seguin C; Bens M; Vandewalle A
    Mol Pharmacol; 2002 Dec; 62(6):1306-13. PubMed ID: 12435797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New naturally occurring missense mutations of the human mineralocorticoid receptor disclose important residues involved in dynamic interactions with deoxyribonucleic acid, intracellular trafficking, and ligand binding.
    Sartorato P; Cluzeaud F; Fagart J; Viengchareun S; Lombès M; Zennaro MC
    Mol Endocrinol; 2004 Sep; 18(9):2151-65. PubMed ID: 15192075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Met852 residue is a key organizer of the ligand-binding cavity of the human mineralocorticoid receptor.
    Fagart J; Seguin C; Pinon GM; Rafestin-Oblin ME
    Mol Pharmacol; 2005 May; 67(5):1714-22. PubMed ID: 15716462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor.
    Quinkler M; Meyer B; Bumke-Vogt C; Grossmann C; Gruber U; Oelkers W; Diederich S; Bahr V
    Eur J Endocrinol; 2002 Jun; 146(6):789-99. PubMed ID: 12039699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor.
    Pippal JB; Cheung CM; Yao YZ; Brennan FE; Fuller PJ
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):58-66. PubMed ID: 20932876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms.
    Hultman ML; Krasnoperova NV; Li S; Du S; Xia C; Dietz JD; Lala DS; Welsch DJ; Hu X
    Mol Endocrinol; 2005 Jun; 19(6):1460-73. PubMed ID: 15761029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteines 849 and 942 of human mineralocorticoid receptor are crucial for steroid binding.
    Lupo B; Mesnier D; Auzou G
    Biochemistry; 1998 Sep; 37(35):12153-9. PubMed ID: 9724527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mineralocorticoid activity of progesterone derivatives depends on the nature of the C18 substituent.
    Souque A; Fagart J; Couette B; Davioud E; Sobrio F; Marquet A; Rafestin-Oblin ME
    Endocrinology; 1995 Dec; 136(12):5651-8. PubMed ID: 7588320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone).
    Dey R; Roychowdhury P
    J Biomol Struct Dyn; 2002 Aug; 20(1):21-9. PubMed ID: 12144349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors.
    Hellal-Levy C; Couette B; Fagart J; Souque A; Gomez-Sanchez C; Rafestin-Oblin M
    FEBS Lett; 1999 Dec; 464(1-2):9-13. PubMed ID: 10611474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of spirolactone recognition by the mineralocorticoid receptor.
    Huyet J; Pinon GM; Fay MR; Fagart J; Rafestin-Oblin ME
    Mol Pharmacol; 2007 Sep; 72(3):563-71. PubMed ID: 17569793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor.
    Li Y; Suino K; Daugherty J; Xu HE
    Mol Cell; 2005 Aug; 19(3):367-80. PubMed ID: 16061183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the human mineralocorticoid receptor gene 5'-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms.
    Zennaro MC; Le Menuet D; Lombès M
    Mol Endocrinol; 1996 Dec; 10(12):1549-60. PubMed ID: 8961265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor.
    Couette B; Jalaguier S; Hellal-Levy C; Lupo B; Fagart J; Auzou G; Rafestin-Oblin ME
    Mol Endocrinol; 1998 Jun; 12(6):855-63. PubMed ID: 9626661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor.
    Govindan MV; Warriar N
    J Biol Chem; 1998 Sep; 273(38):24439-47. PubMed ID: 9733735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure.
    Couette B; Fagart J; Jalaguier S; Lombes M; Souque A; Rafestin-Oblin ME
    Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):421-7. PubMed ID: 8615809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.